Botanical Holdings' Portuguese subsidiary, CECO Wellness (part of the EuroCan division) is commencing civil engineering works for its new medicinal cannabis cultivation and processing facilities in Mação, Portugal. In this facility, it plans to produce products for the international pharmaceutical and medicinal marketplaces.
The new facilities are to be constructed at the 31-hectare site. These facilities will include – in the first phase – a 5,000m2 medicinal cannabis greenhouse, and a 3,600m2 ancillary/support facility for operations including GMP manufacturing, processing, cultivation support services, and warehousing. The development is planned, in the second phase, to further expand the greenhouse footprint to 20,000m2 in total. The initiation of construction activities follows the completion of the initial processes of land acquisition, pre-licensing approval, and pre-construction work.
The construction of new cultivation and processing facilities at the second EuroCan site in Portugal follows the completion of construction at its first site, in Lesotho, earlier in 2021. EuroCan is already undertaking test growing cycles at the 2,800m2 greenhouse and adjoining 800m2 facility (housing production, drying, processing, packing, and office space) in Lesotho. It has already delivered samples to an independent testing laboratory in Maseru, Lesotho. These test growing cycles and independent testing will be used to develop valuable research and refine expertise in the cultivation of cannabis for medicinal purposes. It will also enable EuroCan to achieve good agricultural and collection practices (GACP) accreditation.
EuroCan has chosen to develop sites in both northern and southern hemispheres, in Lesotho and Portugal. This will ensure a stable year-round supply of medicinal cannabis to the pharmaceutical and medicinal marketplaces.
Construction at the EuroCan Portuguese facility has commenced following the award of grant funding of up to €4.3 million ($5.2 million) to CECO Wellness from the Portugal 2020 Fund. This fund is a partnership between the Portuguese government and the European Commission. It also follows Botanical Holdings’ recent £4.5 million ($6.25 million) equity fundraising, in a London Stock Exchange pre-listing round.
“EuroCan commencing construction at the Portuguese facility is a major milestone for the ability of Botanical Holdings to deliver a constant supply of medicinal cannabis to the international pharmaceutical and medicinal marketplaces,” said Carl Esprey, CEO, Botanical Holdings. “Demand from the medicinal cannabis sector continues to increase as international regulations in major global markets change. This in turn is also increasing clinical research and approvals for the therapeutic development of medicinal cannabis. Upon full commissioning of our facilities in Portugal and Lesotho, we will be able to ensure year-round access to cannabis plants, strains, and cannabinoids for those researching medical cannabis and its potential to transform the lives of patients.”
The construction process will follow a detailed timeline, under the oversight of Botanical Holding’s construction and engineering partner, TechnoEdif Engenharia, SA.
For more information: